SE453916B - Nya aromatiska aminoalkoxiderivat, deras framstellningssett och lekemedel anvendbart som kalciumantagonist - Google Patents

Nya aromatiska aminoalkoxiderivat, deras framstellningssett och lekemedel anvendbart som kalciumantagonist

Info

Publication number
SE453916B
SE453916B SE8207224A SE8207224A SE453916B SE 453916 B SE453916 B SE 453916B SE 8207224 A SE8207224 A SE 8207224A SE 8207224 A SE8207224 A SE 8207224A SE 453916 B SE453916 B SE 453916B
Authority
SE
Sweden
Prior art keywords
formula
derivatives
compounds
radical
carbon atoms
Prior art date
Application number
SE8207224A
Other languages
English (en)
Swedish (sv)
Other versions
SE8207224D0 (sv
SE8207224L (sv
Inventor
G Bourgery
A Lacour
B Pourrias
R Santamaria
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8124244A external-priority patent/FR2518992A1/fr
Priority claimed from FR8221053A external-priority patent/FR2537970B1/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of SE8207224D0 publication Critical patent/SE8207224D0/xx
Publication of SE8207224L publication Critical patent/SE8207224L/xx
Publication of SE453916B publication Critical patent/SE453916B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/54—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Peptides Or Proteins (AREA)
SE8207224A 1981-12-24 1982-12-17 Nya aromatiska aminoalkoxiderivat, deras framstellningssett och lekemedel anvendbart som kalciumantagonist SE453916B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8124244A FR2518992A1 (fr) 1981-12-24 1981-12-24 Nouveaux derives aminoalcoxy aromatiques, leur procede de preparation et leur application en therapeutique
FR8221053A FR2537970B1 (fr) 1982-12-15 1982-12-15 Nouveaux derives aminoalkoxy aromatiques, leur procede de preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
SE8207224D0 SE8207224D0 (sv) 1982-12-17
SE8207224L SE8207224L (sv) 1983-06-25
SE453916B true SE453916B (sv) 1988-03-14

Family

ID=26222677

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8207224A SE453916B (sv) 1981-12-24 1982-12-17 Nya aromatiska aminoalkoxiderivat, deras framstellningssett och lekemedel anvendbart som kalciumantagonist
SE8505219A SE8505219D0 (sv) 1981-12-24 1985-11-06 Derives aminoalkoxy aromatiques et leur procede de preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8505219A SE8505219D0 (sv) 1981-12-24 1985-11-06 Derives aminoalkoxy aromatiques et leur procede de preparation

Country Status (13)

Country Link
US (3) US4536500A (fr)
JP (1) JPH04210944A (fr)
AU (1) AU9193482A (fr)
CA (1) CA1197243A (fr)
CH (2) CH661509A5 (fr)
DE (1) DE3247860A1 (fr)
ES (1) ES518518A0 (fr)
GB (2) GB2113680B (fr)
GR (1) GR78370B (fr)
IT (1) IT1191152B (fr)
LU (1) LU84548A1 (fr)
NL (1) NL8204978A (fr)
SE (2) SE453916B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017572A (en) * 1988-04-22 1991-05-21 Delalande S.A. Derivatives of 1-[3-(4-hydroxyphenyl) 1-hydroxy 1-propyl] benzene substituted in position 2 by an aminoalkyleneoxy chain, the method of preparing same and the application thereof to therapeutics
US5270325A (en) * 1988-07-28 1993-12-14 Basf Aktiengesellschaft P-hydroxy phenone derivatives used in the treatment of cardiac arrhythmia
KR0139296B1 (ko) * 1988-11-21 1998-05-15 가와무라 시게꾸니 칼콘 유도체 및 그 제조 방법
US4937235A (en) * 1989-01-23 1990-06-26 American Cyanamid Company 3- or 4-substituted oxotremorine derivatives
FR2646670A1 (fr) * 1989-05-05 1990-11-09 Delalande Sa Utilisation de derives aminoalkoxy aromatiques pour le traitement des troubles du systeme cerebrovasculaire
CA2020888A1 (fr) * 1989-07-27 1991-01-28 Philippe Guerry Derives d'aminoalkoxybenzene substitues
US5214046A (en) * 1989-07-27 1993-05-25 Hoffmann-La Roche Inc. Substituted aminoalkoxybenzene anti-fungicidal compositions and use
US5356891A (en) * 1989-09-22 1994-10-18 Witiak Donald T Phenylalkyl amine derivatives having anti-ischaemic activity
WO1991007958A1 (fr) * 1989-12-06 1991-06-13 Vsesojuzny Kardiologichesky Nauchny Tsentr Preparation pharmaceutique protegeant le myocarde sous ischemie et reperfusion
GB9321811D0 (en) * 1993-10-22 1993-12-15 Smithkline Beecham Plc Pharmaceuticals
FR2734831B1 (fr) * 1995-05-29 1997-07-11 Oreal Composition solide expansee dont la matrice est constituee d'un reseau alveolaire amidonne et contenant des particules de polyamide spheroidales calibrees et utilisations en application topique
JP2001513501A (ja) * 1997-08-07 2001-09-04 イーライ・リリー・アンド・カンパニー エストロゲン阻害活性を有する１−［４−（置換アルコキシ）ベンジル］ナフタレン化合物
US6054246A (en) * 1998-07-01 2000-04-25 Polaroid Corporation Heat and radiation-sensitive imaging medium, and processes for use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB377464A (en) * 1930-08-28 1932-07-28 Chem Ind Basel Manufacture of substituted aromatic ketones
US2668850A (en) * 1952-04-24 1954-02-09 Hoffmann La Roche Phenyl-phenethyl ketones
GB730922A (en) * 1952-04-24 1955-06-01 Roche Products Ltd Aromatic amino-ketones and acid addition salts thereof and a process for the manufacture of same
GB872997A (en) * 1957-01-26 1961-07-19 Pharmacia Ab Substituted ún-aminoalkoxy-acyl benzenes and processes for their manufacture
GB905903A (en) * 1960-05-25 1962-09-12 Guidotti & C Spa Labor Dialkylaminoethoxyketones having a coronary-dilating action and methods of preparingthem
US3077472A (en) * 1961-03-21 1963-02-12 Univ Kansas Res Foundation 3-[4-(aminoalkoxy)-phenyl]-4-(4-oxyphenyl)-alkanes and alkenes
GB1063744A (en) * 1964-05-25 1967-03-30 American Cyanamid Co 4-substituted-4'-tertiary aminoalkoxy biphenyls
GB1111337A (en) * 1964-07-24 1968-04-24 Fisons Pharmaceuticals Ltd Substituted aralkyl alcohols
FR5733M (fr) * 1966-09-27 1968-01-22
GB1388088A (en) * 1973-05-16 1975-03-19 Inst Med Parazitologii I Tropi N-b-2-acetyl-4-chloro-phenoxy-ethyl-n,n-dimethyl-n-benzyl- ammonium-p-chlorobenzene sulphonate method for preparing same and medicinal preparation based thereon

Also Published As

Publication number Publication date
GB2113680B (en) 1986-08-13
US4536500A (en) 1985-08-20
GB8506732D0 (en) 1985-04-17
SE8505219L (sv) 1985-11-06
JPH04210944A (ja) 1992-08-03
DE3247860A1 (de) 1983-07-28
SE8207224D0 (sv) 1982-12-17
NL8204978A (nl) 1983-07-18
SE8207224L (sv) 1983-06-25
GB2154587B (en) 1986-08-20
LU84548A1 (fr) 1984-10-22
AU9193482A (en) 1983-09-01
ES8308864A1 (es) 1983-10-01
GR78370B (fr) 1984-09-26
IT8224964A0 (it) 1982-12-23
GB2113680A (en) 1983-08-10
CH655313A5 (fr) 1986-04-15
SE8505219D0 (sv) 1985-11-06
CH661509A5 (fr) 1987-07-31
ES518518A0 (es) 1983-10-01
CA1197243A (fr) 1985-11-26
GB2154587A (en) 1985-09-11
DE3247860C2 (fr) 1993-08-05
US4831051A (en) 1989-05-16
IT1191152B (it) 1988-02-24
US4732896A (en) 1988-03-22

Similar Documents

Publication Publication Date Title
SU1598865A3 (ru) Способ получени 3-арилокси-3-замещенных пропанаминов или их фармакологически приемлемых кислотно-аддитивных солей
SE453916B (sv) Nya aromatiska aminoalkoxiderivat, deras framstellningssett och lekemedel anvendbart som kalciumantagonist
Thomas et al. Repetitive Diels-Alder reactions for the growth of linear polyacenequinoid derivatives
US4719055A (en) Phenanthrene derivatives
JPH0217179A (ja) 環置換２―アミノ―１，２，３，４―テトラヒドロナフタレン類
JPH03178977A (ja) ジテルペンラクトン化合物及びその製造方法
Garratt et al. Diastereomeric monocyclic diallenes. Synthesis and properties of the diastereomeric 3, 4, 9, 10-cyclododecatetraene-1, 7-diones and 3, 4, 10, 11-cyclotetradecatetraene-1, 8-diones
Mertes et al. Isolation and identification of the cis-trans stereoisomers of substituted 3-hydroxy-(or acetoxy) 2-methyl-2, 3-dihydrobenzofurans. Dihydrobenzofurans which obey the Karplus equation
Piers et al. Total synthesis, stereochemistry, and lithium–ammonia reduction of (±)-4-demethylaristolone and (±)-5-epi-4-demethylaristolone
Dreyer Chemotaxonomy of the Rutaceae. III. Isolation of halfordinol derivatives from Aeglopsis chevalieri
Green et al. Synthesis and pharmacological properties of a series of 2-substituted aminomethyl-1, 4-benzodioxanes
KOIKE et al. Studies on the Alkaloids of Picrasma quassioides BENNET. VIII.: X-Ray Crystal Structure Analysis of Picrasidine-F
Jones et al. Theoretical interpretations of some experimental observations in reactions of triazolopyridines and their quaternary salts
US4474967A (en) 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
Mitchell et al. The synthesis of a cyclophane containing two bridged annulene units
US4716172A (en) 4-substituted octahydroquinolizine analgesic compounds and octahydroquinolizinium intermediates
Stephanidou‐Stephanatou et al. Oxidation of arylacetylhydrazones of carbonyl compounds with lead tetraacetate
US3041355A (en) Products related to muscarine and the preparation of such products
Halton et al. Studies in the cycloproparene series: Approaches to octahydrocyclopropa-[l] phenanthrenes
JPH09202781A (ja) ラディシコール誘導体
Jain et al. Synthesis of isopentenylated chrystins
Sakakibara et al. Photoreaction of methyl 4, 6-O-benzylidene-2, 3-dideoxy-3-nitro-β-d-erythro-hex-2-enopyranoside with 1, 3-dioxolane and tetrahydrofuran
Horton et al. Steric course of triazole formation from acetylenic sugars and phenyl azide
US4642384A (en) Process for the preparation of derivatives of pyrrolidine and piperidine
US4579950A (en) Intermediates for spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine] compounds

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8207224-0

Effective date: 19940710

Format of ref document f/p: F